Capecitabine second-line monotherapy for metastatic breast cancer

被引：0
|
作者：
Vasev, N. [1 ]
Maneva, L. [1 ]
Smickoska, S. [1 ]
Arsovski, O. [1 ]
Stojkovski, I. [1 ]
Milanova, L. [1 ]
机构：
[1] Inst Radiotherapy & Oncol, Dept Breast Canc, Skopje, Macedonia
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：133 / 134
页数：2
相关论文
共 50 条
  • [1] Cost Utility in Second-Line Metastatic Breast Cancer
    Gilles Berdeaux
    Patrick Hurteloup
    [J]. PharmacoEconomics, 1997, 11 : 492 - 495
  • [2] Cost utility in second-line metastatic breast cancer
    Berdeaux, G
    Hurteloup, P
    [J]. PHARMACOECONOMICS, 1997, 11 (05) : 492 - 495
  • [3] Activity of first or second-line capecitabine in metastatic breast cancer (MBC).: A retrospective analysis of its application in the clinic
    Luque, Maria
    Jimenez, Paula
    Fernandez, Yolanda
    Esteban, Emilio
    Maria Buesa, Jose
    Capelan, Marta
    Llorente, Beatriz
    Fra, Joaquin
    Villanueva, Noemi
    [J]. ANNALS OF ONCOLOGY, 2006, 17 : 85 - 85
  • [4] Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer
    Lee S. Schwartzberg
    Patrick Cobb
    Mark S. Walker
    Edward J. Stepanski
    Arthur C. Houts
    [J]. Supportive Care in Cancer, 2009, 17
  • [5] Patient and practice impact of capecitabine compared to taxanes in first-/second-line chemotherapy for metastatic breast cancer
    Schwartzberg, Lee S.
    Cobb, Patrick
    Walker, Mark S.
    Stepanski, Edward J.
    Houts, Arthur C.
    [J]. SUPPORTIVE CARE IN CANCER, 2009, 17 (08) : 1081 - 1088
  • [6] Capecitabine monotherapy in metastatic colorectal cancer - Effectiveness as first, second and third line treatment
    Schaberl-Moser, Renate
    Bauernhofer, Thomas
    Halm, Michael
    Pirchmoser, Renate
    Samonigg, Hellmut
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 95 - 95
  • [7] Combination treatment with aromatase inhibitor and capecitabine as first- or second-line treatment in metastatic breast cancer.
    Alvarado Miranda, Alberto
    Limon, Jesus
    Lara Medina, Fernando
    Arce, Claudia
    Wolfgang Zinser, Juan
    Bargallo Rocha, Enrique
    Mayte Villarreal-Garza, Cynthia
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [8] Cost utility in second-line metastatic breast cancer - Reply
    Launois, R
    ReboulMarty, J
    Henry, B
    Bonneterre, J
    [J]. PHARMACOECONOMICS, 1997, 11 (05) : 495 - 497
  • [9] Treatment Choices for Second-Line Chemotherapy of Metastatic Breast Cancer
    Christoph C. Zielinski
    [J]. Breast Cancer Research and Treatment, 2003, 81 (Suppl 1) : 33 - 36
  • [10] Taxotere as second-line chemotherapy for metastatic breast cancer.
    Culine, S
    [J]. REVUE DE MEDECINE INTERNE, 1999, 20 (03): : 277 - 280
12345